SEC Form 4 · accession 0001064900-15-000003
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheppard Riva
Officer — EXECUTIVE VICE PRESIDENT · Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 9, 2015 · 10:14 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY)F1 | $0.09 | Jun 2, 2015 | A | 250,000 | A | — | Jun 2, 2025 | COMMON STOCK | 250,000 | 250,000 | D |
Explanation of responses
- F1(1) The option vests 75% (187,500) on grant date (June 2, 2015) and in three equal annual installments for the remaining 25% (62,500) beginning on June 2, 2016.